Home
|
Contact
Overview / Mission
Leadership
Culture of RISC
Careers
Contact Us
The Solution
VG102 Cancer Therapeutic
Cocktail Discovery Program
Technology Overview
Targeted Cancer Therapies
Strategic Drug Stockpiles
Predictive Algorithms
Scientific Publications
Metastatic Colorectal Cancer
Lethal, Drug-Resistant Influenza
Company Presentation
News Releases
Events & Industry News
News Releases
Information Request
Corporate Governance
Stock Chart
SEC Filings
Investor FAQ
Information Request
Stock Quote
SEC Filings
News Releases
Corporate Governance
Investor FAQs
Price Data
Welcome
Recent News
Nov 17, 2011
Genesis Biopharma's Scientific and Medical Advisory Board Welcomes Dr. Steven A. Rosenberg, Chief of the Surgery Branch at the NCI
Oct 11, 2011
Genesis Biopharma Signs Worldwide License Agreement with the NIH for Adoptive Cell Therapy to Treat a Variety of Cancers
Sep 19, 2011
Genesis Biopharma Adds Cell Therapy Bioprocess Engineering, Clinical Trial Design, Biostatistics, Regulatory Affairs and FDA Compliance Expertise
Print
Email
© Genesis Biopharma, Inc. 2010 |
Sitemap
Developed by:
Web Advanced